Search Within

Emily H Cheng

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (10)
Groups
  1. Department of Pathology and Laboratory Medicine (42)
  2. GSK Faculty (42)
  3. Human Oncology and Pathogenesis Program (42)
  4. Sloan Kettering Institute Postdocs (42)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (24)
  6. Department of Medicine (23)

More Groups

People
  1. James Hsieh (22)
  2. Yingbei Chen (16)
  3. Abraham Hakimi (14)
  4. Robert Motzer (14)
  5. Shugaku Takeda (14)
  6. Yiyu Dong (14)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (3)
  4. 2019 (4)
  5. 2018 (1)
  6. 2017 (7)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (4)
  3. BJU International (3)
  4. JCI Insight (3)
  5. Journal of Clinical Investigation (3)
  6. Cancer Cell (2)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. Cell Press (6)
  3. American Society of Clinical Oncology (5)
  4. Nature Publishing Group (4)
  5. Amer Soc Clinical Investigation Inc (3)
  6. American Society for Clinical Investigation (3)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
    Journal Article

    Miyazaki, I.; Odintsov, I.; Ishida, K.; Lui, A. J. W.; Kato, M.; Suzuki, T.; Zhang, T.; Wakayama, K.; Kurth, R. I.; Cheng, R.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis
    Journal Article

    Xie, Y.; Sahin, M.; Wakamatsu, T.; Inoue-Yamauchi, A.; Zhao, W.; Han, S.; Nargund, A. M.; Yang, S.; Lyu, Y.; Hsieh, J. J.; more...
    JCI Insight (2023)

    Fulltext@MSK | Save
  • Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Ishizawa, K.; Miyazaki, I.; Khodos, I.; Wakayama, K.; Vojnic, M.; Hagen, C. J.; Chang, Q.; Bonifacio, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes
    Journal Article

    Xie, Y.; Sahin, M.; Sinha, S.; Wang, Y.; Nargund, A. M.; Lyu, Y.; Han, S.; Dong, Y.; Hsieh, J. J.; Leslie, C. S.; more...
    Nature Cancer (2022)

    Fulltext@MSK | Save
  • Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
    Journal Article

    Tanaka, K.; Yu, H. A.; Yang, S.; Han, S.; Selcuklu, S. D.; Kim, K.; Ramani, S.; Ganesan, Y. T.; Moyer, A.; Sinha, S.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA
    Journal Article

    Niizuma, H.; Searleman, A. C.; Takeda, S.; Armstrong, S. A.; Park, C. Y.; Cheng, E. H.; Hsieh, J. J.
    JCI Insight (2021)

    Fulltext@MSK | Save
  • RET inhibition in novel patient-derived models of RET fusion-positive lung adenocarcinoma reveals a role for MYC upregulation
    Journal Article

    Hayashi, T.; Odintsov, I.; Smith, R. S.; Ishizawa, K.; Liu, A. J. W.; Delasos, L.; Kurzatkowski, C.; Tai, H.; Gladstone, E.; Vojnic, M.; more...
    Disease Models & Mechanisms (2021)

    Fulltext@MSK | Save
  • T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage
    Journal Article

    Takashima, S.; Martin, M. L.; Jansen, S. A.; Fu, Y.; Bos, J.; Chandra, D.; O'Connor, M. H.; Mertelsmann, A. M.; Vinci, P.; Kuttiyara, J.; more...
    Science Immunology (2019)

    Fulltext@MSK | Save
  • Enhancing apoptosis to improve the therapy of EGFR-mutant lung cancer
    Meeting Abstract

    Tanaka, K.; Han, S.; Ganesan, Y. T.; Hsieh, J. J.; Cheng, E. H.
    Cancer Research (2019)

    Fulltext@MSK | Save